Literature DB >> 26806607

The tumour hypoxia induced non-coding transcriptome.

Hani Choudhry1, Adrian L Harris2, Alan McIntyre3.   

Abstract

Recent investigations have highlighted the importance of the non-coding genome in regions of hypoxia in tumours. Such regions are frequently found in solid tumours, and are associated with worse patient survival and therapy resistance. Hypoxia stabilises the transcription factors, hypoxia inducible factors (HIF1α and HIF2α) which coordinate transcriptomic changes that occur in hypoxia. The changes in gene expression induced by HIF1α and HIF2α contribute to many of the hallmarks of cancer phenotypes and enable tumour growth, survival and invasion in the hypoxic tumour microenvironment. Non-coding RNAs, in particular microRNAs (miRNAs), which regulate mRNA stability and translation, and long-non-coding RNAs (lncRNAs), which have diverse functions including chromatin modification and transcriptional regulation, are also important in enabling the key hypoxia regulated processes. They have roles in the regulation of metabolism, angiogenesis, autophagy, invasion and metastasis in the hypoxic microenvironment. Furthermore, HIF1α and HIF2α expression and stabilisation are also regulated by both miRNAs and lncRNAs. Here we review the recent developments in the expression, regulation and functions of miRNAs, lncRNAs and other non-coding RNA classes in tumour hypoxia.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Hypoxia; Non-coding RNA; lncRNA; miRNA

Mesh:

Substances:

Year:  2016        PMID: 26806607     DOI: 10.1016/j.mam.2016.01.003

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  45 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 2.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

3.  Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression.

Authors:  Xiao-Lin Hu; Xia-Tong Huang; Jia-Ni Zhang; Jie Liu; Li-Jun Wen; Xin Xu; Jue-Yu Zhou
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

Review 4.  Hypoxia-Induced circRNAs in Human Diseases: From Mechanisms to Potential Applications.

Authors:  Qi Huang; Juan Yang; Robby Miguel Wen-Jing Goh; Mingliang You; Lingzhi Wang; Zhaowu Ma
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

5.  A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer.

Authors:  Xinyang Zhong; Xuefeng He; Yaxian Wang; Zijuan Hu; Deshui Yu; Huixia Huang; Senlin Zhao; Ping Wei; Dawei Li
Journal:  J Immunol Res       Date:  2022-07-08       Impact factor: 4.493

6.  Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks.

Authors:  Neha Upadhyay; Kalpana Tilekar; Sabreena Safuan; Alan P Kumar; Markus Schweipert; Franz-Josef Meyer-Almes; Ramaa C S
Journal:  RSC Med Chem       Date:  2021-07-27

Review 7.  Role of miRNAs in hypoxia-related disorders.

Authors:  A Gupta; R Sugadev; Y K Sharma; Y Yahmad; P Khurana
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

Review 8.  Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism.

Authors:  Fredy O Beltrán-Anaya; Alberto Cedro-Tanda; Alfredo Hidalgo-Miranda; Sandra L Romero-Cordoba
Journal:  Front Physiol       Date:  2016-08-08       Impact factor: 4.566

9.  Circulating lncRNAs HIF1A-AS2 and LINLK-A: Role and Relation to Hypoxia-Inducible Factor-1α in Cerebral Stroke Patients.

Authors:  Heba A Ewida; Rana K Zayed; Hebatallah A Darwish; Amira A Shaheen
Journal:  Mol Neurobiol       Date:  2021-06-05       Impact factor: 5.590

10.  Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway.

Authors:  Changwei Dou; Zhenyu Zhou; Qiuran Xu; Zhikui Liu; Yuqun Zeng; Yufeng Wang; Qing Li; Liang Wang; Wei Yang; Qingguang Liu; Kangsheng Tu
Journal:  Oncogene       Date:  2018-09-24       Impact factor: 8.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.